Figure 4
From: Expression patterns of microRNAs associated with CML phases and their disease related targets
Expression analysis of miR-150 (A.) and its target MYB (B.) in different phases of CML in comparison to control (CONT). CONT = 11, Dg = 13 diagnosis, AP/BC = 12 accelerated phase/blast crisis, Hr = 15 hematological relapse, TF = 14 therapy failure (failure to achieve complete cytogenetic remission), MMR = 16 major molecular response. *** P < 0.001; ** P < 0.01; * P < 0.05